CORTICOSTEROIDS IN THE TREATMENT OF SEVERE COVID-19 LUNG DISEASE: THE PULMONOLOGY PERSPECTIVE FROM THE FIRST UNITED STATES EPICENTER

The SARS-CoV-2 pandemic has introduced the medical community to a lung disease heretofore unknown to most clinicians. In much of the discourse about COVID-19 lung disease, the more familiar clinical entity of ARDS has been used as the guiding paradigm. Reflecting on studies in ARDS, particularly tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Macauley, Precious, Martin, Alvaro, Epelbaum, Oleg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441019/
https://www.ncbi.nlm.nih.gov/pubmed/32829047
http://dx.doi.org/10.1016/j.ijid.2020.08.051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441019/
https://www.ncbi.nlm.nih.gov/pubmed/32829047
http://dx.doi.org/10.1016/j.ijid.2020.08.051

Ejemplares similares